Eculizumab and refractory membranoproliferative glomerulonephritis
This letter to the editor discusses the use of eculizumab in refractory membranoproliferative glomerulonephritis. The response appears to be dramatic.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) Editorial |
| Language: | English |
| Published: |
March 22, 2012
|
| In: |
The New England journal of medicine
Year: 2012, Volume: 366, Issue: 12, Pages: 1165-1166 |
| ISSN: | 1533-4406 |
| DOI: | 10.1056/NEJMc1106619 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1056/NEJMc1106619 Verlag, Volltext: https://doi.org/10.1056/NEJMc1106619 
|
| Author Notes: | Seetha Radhakrishnan, Andrew Lunn, Michael Kirschfink, Paul Thorner, Diane Hebert, Valerie Langlois, Fred Pluthero, Christoph Licht |
| Summary: | This letter to the editor discusses the use of eculizumab in refractory membranoproliferative glomerulonephritis. The response appears to be dramatic. |
|---|---|
| Item Description: | Gesehen am 26.11.2018 |
| Physical Description: | Online Resource |
| ISSN: | 1533-4406 |
| DOI: | 10.1056/NEJMc1106619 |